MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-13-2026
Exact Sciences Corporation Depreciation & Amortization 2011-2026 | EXAS
Annual Depreciation & Amortization Exact Sciences Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125 M | 120 M | 114 M | 100 M | 95 M | 70 M | 34.2 M | 20.5 M | 14.5 M | 11.3 M | 7.6 M | 3.71 M | 1.42 M | 985 K | 411 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 125 M | 411 K | 47.9 M |
Quarterly Depreciation & Amortization Exact Sciences Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31.7 M | 31.1 M | 30 M | - | 30.3 M | 29.7 M | 30.6 M | - | 29.3 M | 27.5 M | 26.8 M | - | 25 M | 25.5 M | 23 M | - | 22.3 M | 21.5 M | 20.5 M | - | 53.3 M | 33.6 M | 16 M | 13.8 M | 21.9 M | 13.5 M | 6.38 M | 734 K | 14.3 M | 8.81 M | 4.28 M | - | 645 K | 290 K | 50 K | - | 150 K | 100 K | 2.47 M | - | - | - | 1.59 M | - | 2.26 M | 1.34 M | 656 K | - | 976 K | 646 K | 314 K | - | 666 K | 417 K | 202 K | - | 262 K | 145 K | 67 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 53.3 M | 50 K | 13.4 M |
Depreciation & Amortization of other stocks in the Diagnostics research industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
ICON Public Limited Company
ICLR
|
488 M | $ 98.33 | 0.9 % | $ 8.11 B |  Irlanda |
 |
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
264 K | - | -6.19 % | $ 10.5 M |  USA |
 |
Charles River Laboratories International
CRL
|
403 M | $ 155.46 | 1.83 % | $ 7.71 B | USA |
 |
Bioventus
BVS
|
47 M | $ 8.62 | 0.23 % | $ 574 M | USA |
 |
DexCom
DXCM
|
252 M | $ 64.24 | -1.56 % | $ 25.1 B | USA |
 |
Castle Biosciences
CSTL
|
16 M | $ 25.56 | 0.95 % | $ 710 M | USA |
 |
CareDx, Inc
CDNA
|
15 M | $ 17.01 | 3.4 % | $ 906 M | USA |
 |
Accelerate Diagnostics
AXDX
|
1.7 M | - | -61.36 % | $ 2.46 M | USA |
 |
Guardant Health
GH
|
39.7 M | $ 85.49 | 1.75 % | $ 10.7 B | USA |
 |
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M |  China |
 |
Fulgent Genetics
FLGT
|
24.9 M | $ 14.77 | 0.61 % | $ 447 M | USA |
|
Biodesix
BDSX
|
5.77 M | $ 17.88 | -6.63 % | $ 2.32 B | USA |
 |
Anixa Biosciences
ANIX
|
38.3 K | $ 2.83 | -1.05 % | $ 91.8 K | USA |
 |
Danaher Corporation
DHR
|
750 M | $ 187.32 | 0.57 % | $ 134 B | USA |
 |
IQVIA Holdings
IQV
|
1.14 B | $ 164.72 | 1.1 % | $ 28.3 B | USA |
 |
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | USA |
 |
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
354 M | $ 118.94 | 2.92 % | $ 18.9 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
570 M | $ 199.7 | -0.46 % | $ 22.2 B | USA |
 |
QIAGEN N.V.
QGEN
|
203 M | - | - | $ 10.6 B |  Niderland |
 |
Agilent Technologies
A
|
321 M | $ 111.51 | -0.06 % | $ 33.9 B | USA |
 |
BioNano Genomics
BNGO
|
14 M | $ 1.11 | -0.89 % | $ 1.41 M | USA |
 |
DarioHealth Corp.
DRIO
|
473 K | $ 9.0 | -0.99 % | $ 255 M |  Israel |
 |
Neogen Corporation
NEOG
|
119 M | $ 9.09 | -2.78 % | $ 1.97 B | USA |
 |
National Research Corporation
NRC
|
7.62 M | $ 16.52 | 0.12 % | $ 370 M | USA |
 |
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
161 K | - | - | $ 9.42 M | Israel |
 |
Pacific Biosciences of California
PACB
|
13 M | $ 1.33 | 4.72 % | $ 399 M | USA |
 |
Co-Diagnostics
CODX
|
1.23 M | - | - | $ 79.8 M | USA |
 |
Medpace Holdings
MEDP
|
27.2 M | $ 450.41 | 1.48 % | $ 13 B | USA |
 |
Celcuity
CELC
|
130 K | $ 114.22 | 3.11 % | $ 4.51 B | USA |
 |
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | USA |
 |
Mettler-Toledo International
MTD
|
51.1 M | $ 1 173.74 | 0.49 % | $ 24.2 B |  Schweiz |
 |
Personalis
PSNL
|
10.9 M | $ 6.72 | 1.97 % | $ 398 M | USA |
 |
NeoGenomics
NEO
|
36.1 M | $ 7.88 | -1.25 % | $ 1.01 B | USA |
 |
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K | USA |
 |
Natera
NTRA
|
16.7 M | $ 187.85 | -1.29 % | $ 18.5 B | USA |
 |
Sotera Health Company
SHC
|
94.9 M | $ 13.42 | 0.71 % | $ 3.81 B | USA |
 |
Invitae Corporation
NVTA
|
142 M | - | - | $ 21.2 M | USA |
 |
OPKO Health
OPK
|
98.2 M | $ 1.19 | 2.59 % | $ 826 M | USA |